This is a study for women who have advanced recurrent ovarian cancer, specifically high-grade serious ovarian cancer that is platinum resistant. The Principal Investigators of this study is Ritu Salani, MD, Division Director for UCLA Gynecologic Oncology. For more information >
The UCLA OBGYN physicians are nationally and internationally recognized not only for their clinical expertise but also for their pioneering research. Our goal is to increase basic research and translate the findings into clinical trials.
What is a clinical trial? A clinical trial is a study conducted with actual patients, usually to evaluate a new treatment. Each study is designed to answer scientific questions and to find new and better ways to help our patients.
Cancer - Ovarian, Fallopian Tube and Peritoneal Cancer
Cancer - Uterine and Endometrial
Cancer - Cervical
Currently Enrolling
Women at High Risk for Ovarian and Breast Cancers
Benign / Non-Cancer
Currently Enrolling
Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant
Androgen Excess as a Mechanism for Adipogenic Dysfunction in PCOS Women
Research Studies
Currently Enrolling
Research Study for Women With Regular and Irregular Menstrual Cycles
PRIORITY (Pregnancy CoRonavirus Outcomes RegIsTrY) is a nationwide study of pregnant or recently pregnant women who are either under investigation for Coronavirus infection (COVID-19) or have been confirmed to have COVID-19. Yalda Afshar, MD, PhD, a UCLA OBGYN maternal fetal medicine specialist, is a CO-PI on this study that is overseen by a team from UCSF and which is being done to help patients and doctors better understand how COVID-19 impacts pregnant women and their newborns. For more information > | Study flyer >
For more information about clinical trials at UCLA Obstetrics and Gynecology, please contact:
Jenny Lester, MPH, CCRP
Director of Clinical Trials
Obstetrics and Gynecology, David Geffen School of Medicine at UCLA
Phone: 310-794-9728
Email: [email protected]
Clinical Trial Resources:
